REFERENCES
- Niu C.H., Chiu Y.Y. FDA perspective on peptide formulation and stability issues. J. Pharm. Sci. 1998; 87((11))1331–1334
- Putney S.D., Burke P.A. Improving protein therapeutics with sustained-release formulations. Nat. Biotechnol. 1998; 16((2))153–157
- Rothen-Weinhold A., Besseghir K., De Zelicourt Y., Gurny R. Development and evaluation in vivo of a long-term delivery system for vapreotide, a somatostatin analog. J. Control. Release 1998; 52((1,2))205–213
- Schwendeman S.P., Cardamone M., Klibanov A., Langer R., Brandon M.R. Stability of proteins and their delivery from biodegradable polymer microspheres. Drugs Pharm. Sci. 1996; 1–49
- Shenderova A., Burke T.G., Schwendeman S.P. Evidence for an acidic microclimate in PLGA microspheres. Proc. Int. Symp. Control. Release Bioact. Mater. 1998; 25: 265–266
- Brunner A., Mäder K., Göpferich A. The chemical microenvironment inside biodegradable microspheres during erosion. Proc. Int. Symp. Control. Release Bioact. Mater. 1998; 25: 154–155
- Lucke A., Kiermaier J., Goepferich A. Peptide acylation by poly(α-hydroxy esters). Pharmacol. Res. 2002; 19((2))175–181
- Reithmeier H., Gopferich A., Herrmann J. Preparation and characterization of lipid microparticles containing thymocartin, an immunomodulating peptide. Proc. Int. Symp. Control. Release Bioact. Mater. 1999; 26: 681–682
- Zur M., Schwarz C., Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery. Drug release and release mechanism. Eur. J. Pharm. Biopharm. 1998; 45((2))149–155
- Reithmeier H., Herrmann J., Gopferich A. Development and characterization of lipid microparticles as a drug carrier for somatostatin. Int. J. Pharm. 2001; 218((1–2))133–143
- , Vogelhuber, W.; Magni, E.; Gazzaniga, A.; Goepferich, A.M. Monolithic glyceryl trimyristate matrices for parenteral drug release applications. Eur. J. Pharm. Biopharm. (submitted 2002).
- Göpferich A., Langer R. Modeling of polymer erosion in three dimensions: rotationally symmetric devices. AIChE J. 1995; 41((10))2292–2299
- Muckenschnabel I., Bernhardt G., Spruss T., Dietl B., Buschauer A. Quantitation of hyaluronidases by the Morgan–Elson reaction: comparison of the enzyme activities in the plasma of tumor patients and healthy volunteers. Cancer Lett. 1998; 131((1))13–20
- Spruß T., Schlemmer R., Bernhardt G., Wiesenmeyer F., Baumann O. W. Arnold, P. Koepf-Maier, B. MicheelFive-year breeding data, immunology and tumor take rates of an NMRI nude mouse colony. Immunodeficient Laboratory Animals, . Karger, Basel 1996; 12–18
- Reithmeier H. Entwicklung und charakterisierung von lipidmikropartikeln als parenterale depotarzneiform für peptide. Ph.D. Thesis. Univ. Regensburg. 1999
- Jiang W., Schwendeman S.P. Stabilization and controlled release of bovine serum albumin encapsulated in poly(D,L-lactide) and poly(ethylene glycol) microsphere blends. Pharmacol. Res. 2001; 18: 878–885
- Menzel E.J., Farr C. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. Cancer Lett. 1998; 131((1))3–11
- , Maschke, A.; Lucke, A; Vogelhuber, W.; Fischbach, C.; Appel, B.; Blunk, T.; Göpferich, A. Lipids: An Alternative Material for Protein and Peptide Release, ACS Symposium Series Book chapter, in preparation (2002).